Jacques Pierre Moreau
Direttore/Membro del Consiglio presso Mulleris Therapeutics, Inc.
Profilo
Jacques Pierre Moreau is the founder of Biomeasure, Inc. which was founded in 1976.
He is also the founder of ProteoThera, Inc. Dr. Moreau's current jobs include Director positions at Mulleris Therapeutics, Inc. and Chondiothera, Inc. Dr. Moreau's former jobs include Non-Executive Director at Dr. Reddy's Laboratories Ltd., Director at Tercica, Inc., Director at Phytomedics, Inc., and Chief Scientific Officer & Executive VP at Ipsen SA. Dr. Moreau received an undergraduate degree from the University of Orléans.
Posizioni attive di Jacques Pierre Moreau
Società | Posizione | Inizio |
---|---|---|
Mulleris Therapeutics, Inc. | Direttore/Membro del Consiglio | - |
Chondiothera, Inc. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jacques Pierre Moreau
Società | Posizione | Fine |
---|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Direttore/Membro del Consiglio | 03/02/2014 |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Direttore/Membro del Consiglio | 03/12/2012 |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Fondatore | - |
IPSEN | Direttore Tecnico/Scientifico/R&S | - |
Biomeasure, Inc.
Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Amministratore Delegato | - |
Formazione di Jacques Pierre Moreau
University of Orléans | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
DR. REDDY'S LABORATORIES LIMITED | Health Technology |
IPSEN | Health Technology |
Aziende private | 6 |
---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Health Technology |
Biomeasure, Inc.
Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Health Technology |
Mulleris Therapeutics, Inc. | |
Chondiothera, Inc. | |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Health Technology |
- Borsa valori
- Insiders
- Jacques Pierre Moreau